Sheffield Wednesday’s prospective new owners will be able to buy the club without going through the Independent Regulator's new beefed-up owners and directors test – but could be subjected to it later ...

Tesla may have celebrated a regulatory win in Europe a bit too soon. Tesla claimed in a weekend social media post that Dutch regulator RDW was set to approve the use of its driver assistance system, ...

Mineral Resources’ has overhauled rules for how staff can trade shares as part of the miner’s efforts to address the litany of governance failures that have made it a target of the tax office and the ...

A newly approved diagnostic test could give UK clinicians a more accurate way to identify latent and active tuberculosis (TB). The Medicines and Healthcare products Regulatory Agency (MHRA) has ...

Chainlink and Apex Group said they completed a pilot project with Bermuda’s financial regulator, the Bermuda Monetary Authority, to test how blockchain infrastructure can help enforce stablecoin rules ...

"Whenever a small group of dominant companies gains control of an emerging industry, competitive risks are inevitable," Mogin Law wrote in a note to clients. Nvidia's recent wave of ...

Tesla CEO Elon Musk helped fire dozens of workers at the National Highway Traffic Safety Administration earlier this year. This week, the U.S. Senate voted 51-47 to confirm Jonathan Morrison to lead ...

Tesla has received approval to test its autonomous vehicles with human safety drivers in Phoenix. The company is not yet permitted to operate a commercial ridesharing service in the city. Tesla aims ...

The EU’s landmark crypto law was meant to unify the market with a single license. Less than a year in, diverging national approaches are raising fears of regulatory arbitrage and uncertainty. As the ...

The Independent Football Regulator (IFR) has revealed the first weapon in its arsenal to protect English clubs from bankruptcy: a beefed-up fit-and-proper person test that could see rogue owners ...

Trinity Biotech's American depositary receipts surged after the company received approval from New York regulators to start providing tests that assess the risk of preeclampsia in pregnant patients.